Black Diamond Therapeutics Inc (NAS:BDTX)
$ 3.31 0.09 (2.8%) Market Cap: 187.03 Mil Enterprise Value: 82.76 Mil PE Ratio: 0 PB Ratio: 1.68 GF Score: 41/100

Black Diamond Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 07:35PM GMT
Release Date Price: $3.48 (-0.29%)
Unidentified Participant

Hi, thank you very much for stopping by the fireside chat. We're really pleased to welcome David from Black Diamond. We'd like to thank you for making the trip out here and spending some time with us today.

Before we get started, I have a brief research disclosure that I need to read. For important disclosures please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Unidentified Participant;David M. Epstein
Black Diamond Therapeutics, Inc. - Co-Founder,

David, good to have you on the conference today. It's been a very exciting couple of months for Black Diamond and just the broader field, I think for some context, maybe can you just provide an overview of Black Diamond for those that may not be familiar and also in particular your recent update from June.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot